Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Five Point Holdings
FPH
$376M
| $458K | ﹤0.01% |
70,087
-3,886
| -5% | -$26.2K |
|
|
LKFT
3227
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
| $455K | ﹤0.01% |
8,261
| – | – |
|
3228
Bridgewater Bancshares
BWB
$571M
| $453K | ﹤0.01% |
25,560
+16,889
| +195% | +$302K |
|
3229
Geron
GERN
$828M
| $452K | ﹤0.01% |
369,932
+234,238
| +173% | +$336K |
|
3230
PUT
General Mills
GIS
$19.1B
| $451K | ﹤0.01% |
6,700
| – | – |
|
3231
Forestar Group
FOR
$1.44B
| $450K | ﹤0.01% |
20,706
+12,395
| +149% | +$255K |
|
3232
PUT
Eaton
ETN
$161B
| $449K | ﹤0.01% |
2,600
| – | – |
|
3233
Peoples Financial Services
PFIS
$704M
| $448K | ﹤0.01% |
8,514
+5,646
| +197% | +$273K |
|
3234
RBB Bancorp
RBB
$448M
| $447K | ﹤0.01% |
17,081
+11,170
| +189% | +$285K |
|
3235
KVH Industries
KVHI
$181M
| $446K | ﹤0.01% |
48,517
+12,204
| +34% | +$122K |
|
3236
Cato Corp
CATO
$68.3M
| $444K | ﹤0.01% |
25,888
+10,088
| +64% | +$174K |
|
|
TRHC
3237
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $442K | ﹤0.01% |
29,451
+10,130
| +52% | +$184K |
|
3238
Quantum Corp
QMCO
$419M
| $441K | ﹤0.01% |
4,002
+2,374
| +146% | +$271K |
|
3239
SIGA Technologies
SIGA
$235M
| $440K | ﹤0.01% |
58,561
+35,101
| +150% | +$267K |
|
3240
PUT
Signet Jewelers
SIG
$3.61B
| $435K | ﹤0.01% |
5,000
| – | – |
|
3241
AXT Inc
AXTI
$3.95B
| $433K | ﹤0.01% |
49,137
+28,745
| +141% | +$243K |
|
3242
NextCure
NXTC
$16.8M
| $432K | ﹤0.01% |
5,996
-201
| -3% | -$16.8K |
|
3243
Greif Class B
GEF.B
$4.11B
| $430K | ﹤0.01% |
7,198
+4,774
| +197% | +$307K |
|
3244
Verastem
VSTM
$510M
| $429K | ﹤0.01% |
17,436
+11,457
| +192% | +$362K |
|
|
FNGA
3245
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
| $429K | ﹤0.01% |
1,143
-229
| -17% | -$92.9K |
|
|
AKTS
3246
DELISTED
Akoustis Technologies Inc
AKTS
| $429K | ﹤0.01% |
64,107
+43,616
| +213% | +$326K |
|
|
ARNA
3247
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $428K | ﹤0.01% |
+4,600
| New | +$303K |
|
3248
Atlanticus Holdings
ATLC
$1.59B
| $426K | ﹤0.01% |
5,964
+3,778
| +173% | +$253K |
|
3249
Aviat Networks
AVNW
$265M
| $426K | ﹤0.01% |
13,265
+9,325
| +237% | +$291K |
|
3250
BioXcel Therapeutics
BTAI
$24.9M
| $426K | ﹤0.01% |
1,308
+662
| +102% | +$284K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.